Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Precision Optics Corporation, Inc. (POCI)

Compare
3.9000
-0.2500
(-6.02%)
At close: 4:00:00 PM EDT
Loading Chart for POCI
  • Previous Close 4.1500
  • Open 4.1200
  • Bid --
  • Ask --
  • Day's Range 3.9000 - 4.1500
  • 52 Week Range 3.4700 - 6.9000
  • Volume 25,394
  • Avg. Volume 11,543
  • Market Cap (intraday) 29.786M
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6500
  • Earnings Date May 13, 2025 - May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.

www.poci.com

83

Full Time Employees

June 30

Fiscal Year Ends

Recent News: POCI

View More

Performance Overview: POCI

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

POCI
19.09%
S&P 500 (^GSPC)
4.23%

1-Year Return

POCI
31.82%
S&P 500 (^GSPC)
7.42%

3-Year Return

POCI
35.00%
S&P 500 (^GSPC)
23.92%

5-Year Return

POCI
6.47%
S&P 500 (^GSPC)
128.01%

Compare To: POCI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: POCI

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    31.32M

  • Enterprise Value

    34.19M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.36

  • Price/Book (mrq)

    3.31

  • Enterprise Value/Revenue

    1.83

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -21.46%

  • Return on Assets (ttm)

    -13.39%

  • Return on Equity (ttm)

    -38.56%

  • Revenue (ttm)

    18.68M

  • Net Income Avi to Common (ttm)

    -4.01M

  • Diluted EPS (ttm)

    -0.6500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    212.44k

  • Total Debt/Equity (mrq)

    32.58%

  • Levered Free Cash Flow (ttm)

    -974.2k

Research Analysis: POCI

View More

Company Insights: POCI

Research Reports: POCI

View More

People Also Watch